395 related articles for article (PubMed ID: 36835588)
1. Application Progress of the Single Domain Antibody in Medicine.
Tang H; Gao Y; Han J
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36835588
[TBL] [Abstract][Full Text] [Related]
2. Introduction to heavy chain antibodies and derived Nanobodies.
Vincke C; Muyldermans S
Methods Mol Biol; 2012; 911():15-26. PubMed ID: 22886243
[TBL] [Abstract][Full Text] [Related]
3. Nanobodies as efficient drug-carriers: Progress and trends in chemotherapy.
Panikar SS; Banu N; Haramati J; Del Toro-Arreola S; Riera Leal A; Salas P
J Control Release; 2021 Jun; 334():389-412. PubMed ID: 33964364
[TBL] [Abstract][Full Text] [Related]
4. Single Domain Antibody application in bacterial infection diagnosis and neutralization.
Qin Q; Liu H; He W; Guo Y; Zhang J; She J; Zheng F; Zhang S; Muyldermans S; Wen Y
Front Immunol; 2022; 13():1014377. PubMed ID: 36248787
[TBL] [Abstract][Full Text] [Related]
5. Identification of Useful Nanobodies by Phage Display of Immune Single Domain Libraries Derived from Camelid Heavy Chain Antibodies.
Romao E; Morales-Yanez F; Hu Y; Crauwels M; De Pauw P; Hassanzadeh GG; Devoogdt N; Ackaert C; Vincke C; Muyldermans S
Curr Pharm Des; 2016; 22(43):6500-6518. PubMed ID: 27669966
[TBL] [Abstract][Full Text] [Related]
6. Nanobodies and Nanobody-Based Human Heavy Chain Antibodies As Antitumor Therapeutics.
Bannas P; Hambach J; Koch-Nolte F
Front Immunol; 2017; 8():1603. PubMed ID: 29213270
[TBL] [Abstract][Full Text] [Related]
7. Immunoreaction of a recombinant nanobody from camelid single domain antibody fragment with Acinetobacter baumannii.
Payandeh Z; Rasooli I; Mousavi Gargari SL; Rajabi Bazl M; Ebrahimizadeh W
Trans R Soc Trop Med Hyg; 2014 Feb; 108(2):92-8. PubMed ID: 24463583
[TBL] [Abstract][Full Text] [Related]
8. Camelid Single-Domain Antibodies: Promises and Challenges as Lifesaving Treatments.
Arbabi-Ghahroudi M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563400
[TBL] [Abstract][Full Text] [Related]
9. NanoBERTa-ASP: predicting nanobody paratope based on a pretrained RoBERTa model.
Li S; Meng X; Li R; Huang B; Wang X
BMC Bioinformatics; 2024 Mar; 25(1):122. PubMed ID: 38515052
[TBL] [Abstract][Full Text] [Related]
10. Nanobodies as versatile tools: A focus on targeted tumor therapy, tumor imaging and diagnostics.
Al-Baradie RS
Hum Antibodies; 2020; 28(4):259-272. PubMed ID: 32831197
[TBL] [Abstract][Full Text] [Related]
11. [Progress in nanobody and its application in diagnosis].
Kong Q; Yao Y; Chen R; Lu S
Sheng Wu Gong Cheng Xue Bao; 2014 Sep; 30(9):1351-61. PubMed ID: 25720150
[TBL] [Abstract][Full Text] [Related]
12. [Single-domain antibody - advances in research and application].
Kang X; Cao J; Zhang B; Yuan Q
Sheng Wu Gong Cheng Xue Bao; 2018 Dec; 34(12):1974-1984. PubMed ID: 30584708
[TBL] [Abstract][Full Text] [Related]
13. Nanobodies: from structure to applications in non-injectable and bispecific biotherapeutic development.
Li B; Qin X; Mi LZ
Nanoscale; 2022 May; 14(19):7110-7122. PubMed ID: 35535618
[TBL] [Abstract][Full Text] [Related]
14. NANOBODIES®: A Review of Diagnostic and Therapeutic Applications.
Jin BK; Odongo S; Radwanska M; Magez S
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36983063
[TBL] [Abstract][Full Text] [Related]
15. Joining the in vitro immunization of alpaca lymphocytes and phage display: rapid and cost effective pipeline for sdAb synthesis.
Comor L; Dolinska S; Bhide K; Pulzova L; Jiménez-Munguía I; Bencurova E; Flachbartova Z; Potocnakova L; Kanova E; Bhide M
Microb Cell Fact; 2017 Jan; 16(1):13. PubMed ID: 28114943
[TBL] [Abstract][Full Text] [Related]
16. Structural Insights into the Design of Synthetic Nanobody Libraries.
Valdés-Tresanco MS; Molina-Zapata A; Pose AG; Moreno E
Molecules; 2022 Mar; 27(7):. PubMed ID: 35408597
[TBL] [Abstract][Full Text] [Related]
17. Combining of synthetic VHH and immune scFv libraries for pregnancy-associated glycoproteins ELISA development.
Dormeshkin D; Shapira M; Karputs A; Kavaleuski A; Kuzminski I; Stepanova E; Gilep A
Appl Microbiol Biotechnol; 2022 Aug; 106(13-16):5093-5103. PubMed ID: 35723693
[TBL] [Abstract][Full Text] [Related]
18. Easily Established and Multifunctional Synthetic Nanobody Libraries as Research Tools.
Liu B; Yang D
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163405
[TBL] [Abstract][Full Text] [Related]
19. Isolation and optimization of camelid single-domain antibodies: Dirk Saerens' work on nanobodies.
Saerens D
World J Biol Chem; 2010 Jul; 1(7):235-8. PubMed ID: 21537479
[TBL] [Abstract][Full Text] [Related]
20. Development of Antibody and Nanobody Tools for P2X7.
Stähler T; Danquah W; Demeules M; Gondé H; Hardet R; Haag F; Adriouch S; Koch-Nolte F; Menzel S
Methods Mol Biol; 2022; 2510():99-127. PubMed ID: 35776322
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
